Suboxone 3 mg (Naloxone (Naloxone Hydrochloride) FILM, SOLUBLE) 3 MG

SUBOXONE 3 MG film is a buccal medication containing naloxone hydrochloride, used for opioid dependence treatment. This soluble film dissolves in the mouth for easy administration.

Strength

3 MG

Manufacturer / TM Owner

INDIVIOR UK LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SUBOXONE 3 MG is primarily used in the management of opioid dependence. It works by reducing cravings and withdrawal symptoms, helping individuals maintain abstinence from opioids. The medication is part of a comprehensive treatment plan that includes counseling and psychosocial support. What is SUBOXONE used for? It is specifically formulated to aid in the recovery process from opioid addiction.

Side Effects

Common effects of SUBOXONE 3 MG may include nausea, vomiting, headache, and sweating. Some users might experience insomnia, constipation, or dizziness. These effects can vary from person to person and typically subside as the body adjusts to the medication.

Precautions & Warnings

SUBOXONE 3 MG should be used with caution in individuals with a history of liver or kidney disease. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. The film should be placed under the tongue or inside the cheek and allowed to dissolve completely.

Avoid Interactions

SUBOXONE 3 MG may interact with other medications, including benzodiazepines, sedatives, and certain antidepressants. Alcohol consumption should be avoided while using this medication, as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

SUBOXONE 3 MG is used to manage opioid dependence by reducing cravings and withdrawal symptoms.

The film should be placed under the tongue or inside the cheek and allowed to dissolve completely.

Common side effects may include nausea, vomiting, headache, sweating, insomnia, constipation, and dizziness.

SUBOXONE 3 MG may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Alcohol consumption should be avoided while using SUBOXONE 3 MG, as it can increase the risk of side effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.